Literature DB >> 35440143

Adeno-Associated Virus Toolkit to Target Diverse Brain Cells.

Rosemary C Challis1, Sripriya Ravindra Kumar1, Xinhong Chen1, David Goertsen1, Gerard M Coughlin1, Acacia M Hori1, Miguel R Chuapoco1, Thomas S Otis2, Timothy F Miles1, Viviana Gradinaru1.   

Abstract

Recombinant adeno-associated viruses (AAVs) are commonly used gene delivery vehicles for neuroscience research. They have two engineerable features: the capsid (outer protein shell) and cargo (encapsulated genome). These features can be modified to enhance cell type or tissue tropism and control transgene expression, respectively. Several engineered AAV capsids with unique tropisms have been identified, including variants with enhanced central nervous system transduction, cell type specificity, and retrograde transport in neurons. Pairing these AAVs with modern gene regulatory elements and state-of-the-art reporter, sensor, and effector cargo enables highly specific transgene expression for anatomical and functional analyses of brain cells and circuits. Here, we discuss recent advances that provide a comprehensive (capsid and cargo) AAV toolkit for genetic access to molecularly defined brain cell types.

Entities:  

Keywords:  AAV; adeno-associated virus; systemic delivery; targeted brain delivery; viral capsid engineering; viral cargo

Mesh:

Year:  2022        PMID: 35440143     DOI: 10.1146/annurev-neuro-111020-100834

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   15.553


  4 in total

1.  Engineered AAVs for non-invasive gene delivery to rodent and non-human primate nervous systems.

Authors:  Xinhong Chen; Sripriya Ravindra Kumar; Cameron D Adams; Daping Yang; Tongtong Wang; Damien A Wolfe; Cynthia M Arokiaraj; Victoria Ngo; Lillian J Campos; Jessica A Griffiths; Takako Ichiki; Sarkis K Mazmanian; Peregrine B Osborne; Janet R Keast; Cory T Miller; Andrew S Fox; Isaac M Chiu; Viviana Gradinaru
Journal:  Neuron       Date:  2022-05-27       Impact factor: 18.688

Review 2.  Optogenetic Methods to Investigate Brain Alterations in Preclinical Models.

Authors:  Marco Brondi; Matteo Bruzzone; Claudia Lodovichi; Marco Dal Maschio
Journal:  Cells       Date:  2022-06-05       Impact factor: 7.666

3.  The promise of gene editing: so close and yet so perilously far.

Authors:  David J Segal
Journal:  Front Genome Ed       Date:  2022-07-15

4.  Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model.

Authors:  Ren Song; Katja Pekrun; Themasap A Khan; Feijie Zhang; Sergiu P Paşca; Mark A Kay
Journal:  Mol Ther Methods Clin Dev       Date:  2022-09-07       Impact factor: 5.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.